Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 1867971Generated: October 30, 2026

Diisopropylethylamine → HCID 86612149, compound

https://huagongshe.com/reaction/1867971

Reaction equation

Participants

RoleNameHCIDCharge
ReactantDiisopropylethylamineHCID 81531—
Reactant[1-(tert-Butoxycarbonyl)piperidin-4-yl]acetic acidHCID 1512539—
ReactantMethanaminium, N-((1H-benzotriazol-1-yloxy)(dimethylamino)methylene)-N-methyl-, hexafluorophosphate(1-) (1:1)HCID 2733084—
ReactantHCID 57980859HCID 57980859—
SolventWaterHCID 962—
SolventDimethylformamideHCID 6228—
ProductHCID 86612149HCID 86612149—

Reaction Steps

1st step: A solution of 4-isobutylaminobenzenesulfonic acid 2-aminobenzo-thiazol-6-yl ester (intermediate 27) (300 mg, 0.495 mmol), 4-carboxymethyl-piperidine-1-carboxylic acid tert-butyl ester (361 mg, 1.485 mmol), HBTU (563 mg, 1.485 mmol) and N,N-diisopropylethylamine (432 μl, 2.475 mmol) in 4 ml of dimethylformamide is stirred at room temperature overnight. Water is added to the reaction medium, which is extracted with ethyl acetate. The organic phase is washed with water and then with saturated sodium chloride solution, dried over magnesium sulfate and concentrated to dryness. The residue obtained is purified by HPLC on a Dynamax C18, 60 Å, 21×300 mm column with a 95/5 mixture of water/acetonitrile, for 5 minutes, with a gradient of from 5% to 40% in water for 5 minutes, with a gradient of from 40% to 80% of acetonitrile in water for 30 minutes, with a gradient of from 80% to 95% of acetonitrile in water for 5 minutes, and then with a 5/95 mixture of water/acetonitrile for 5 minutes with a flow rate of 20 ml/minute. The solvents each contain 0.07% (v/v) of trifluoroacetic acid. The fractions are collected every 30 seconds and are monitored by analytical HPLC on a Hypersil C18, 4.6×50 mm column, with a gradient of from 0 to 100% of acetonitrile in water, over 10 minutes at a flow rate of 1 ml/minute. The solvents each contain 0.07% (v/v) of trifluoroacetic acid. The fractions containing the expected product are concentrated to dryness to give 4-{[6-(4-isobutylamino-benzenesulfonyloxy)benzothiazol-2-ylcarbamoyl]methyl}piperidine-1-carboxylic acid tert-butyl ester.

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS07632952B2
Source datasetuspto-grants-2009_12
ORD IDord-7a647fb1e98c464fb98ccb2f177862cd
Source noteuspto-grants-2009_12